The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

The move places the company in competition with other direct-to-consumer marketplaces including Hims & Hers Health and Ro.

Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...

Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Hims & Hers (HIMS) fell 17% Thursday after Amazon (AMZN) announced it was launching an expanded pay-per-visit telehealth ...

The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...

In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...